Placenta suppresses experimental autoimmune hypophysitis through soluble TNF receptor 1

Journal of Autoimmunity

Volumn 38, Issue 2-3, 2012, Pages

  Landek Salgado, Melissa A ^a   Rose, Noel R ^a,b   Caturegli, Patrizio ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hypophysitis; Pituitary antibodies; Placenta; Pregnancy; TNF

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLACENTA PROTEIN; TETANUS TOXOID; THYROGLOBULIN; TUBERCULIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CELL INFILTRATION; CONTROLLED STUDY; DECIDUA; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HYPOPHYSIS; HYPOPHYSITIS; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; THYROID GLAND;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; PITUITARY DISEASES; PITUITARY GLAND; PLACENTA; PREGNANCY; PROTEIN BINDING; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; THYROGLOBULIN; THYROIDITIS, AUTOIMMUNE;

EID: 84858745219     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.07.001     Document Type: Article

References (50)

1. Borchers A.T., Naguwa S.M., Keen C.L., Gershwin M.E. The implications of autoimmunity and pregnancy. J Autoimmun 2010, 34:J287-J299.
2. Lee M., O'Brien P. Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry 2008, 79:1308-1311.
3. Ostensen M., Brucato A., Carp H., Chambers C., Dolhain R.J., Doria A., et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 2010.
4. Landek-Salgado M.A., Gutenberg A., Lupi I., Kimura H., Mariotti S., Rose N.R., et al. Pregnancy, postpartum autoimmune thyroiditis, and autoimmune hypophysitis: intimate relationships. Autoimmun Rev 2010, 9:153-157.
5. Cavanagh A.C., Morton H. The purification of early-pregnancy factor to homogeneity from human platelets and identification as chaperonin 10. Eur J Biochem 1994, 222:551-560.
6. Morton H., Hegh V., Clunie G.J.A. Studies of the Rosette inhibition test in pregnant mice: evidence of immunosuppression?. Proc R Soc Lond B 1976, 193:413-419.
7. Zhang B., Harness J., Somodevilla-Torres M.J., Hillyard N.C., Mould A.W., Alewood D., et al. Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151. J Neurol Sci 2000, 182:5-15.
8. Zhang B., Walsh M.D., Nguyen K.B., Hillyard N.C., Cavanagh A.C., McCombe P.A., et al. Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitrochlorobenzene in normal BALB/c mice. J Neurol Sci 2003, 212:37-46.
9. Langer-Gould A., Garren H., Slansky A., Ruiz P.J., Steinman L. Late pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: evidence for a suppressive pregnancy-related serum factor. J Immunol 2002, 169:1084-1091.
10. McClain M.A., Gatson N.N., Powell N.D., Papenfuss T.L., Gienapp I.E., Song F., et al. Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production. J Immunol 2007, 179:8146-8152.
11. Gatson N.N., Williams J.L., Powell N.D., McClain M.A., Hennon T.R., Robbins P.D., et al. Induction of pregnancy during established EAE halts progression of CNS autoimmune injury via pregnancy-specific serum factors. J Neuroimmunol 2010, 10.1016/j.jneuroim.2010.09.010.
12. Barac-Latas V., Muhvic D., Radosevic-Stabic B. The influence of pregnancy on development and course of chronic relapsing experimental autoimmune encephalomyelitis in rats: implications for multiple sclerosis. Coll Antropol 2010, 34(Suppl. 1):267-271.
13. Imaizumi M., Pritsker A., Kita M., Ahmad L., Unger P., Davies T. Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies. Endocrinology 2001, 142:823-829.
14. Imaizumi M., Pritsker A., Kita M., Ahmad L., Unger P., Davies T.F. Non-MHC driven exacerbation of experimental thyroiditis in the postpartum period. Autoimmunity 2001, 34:95-105.
15. Kokeny G., Godo M., Nagy E., Kardos M., Kotsch K., Casalis P., et al. Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice. Lupus 2007, 16:465-477.
16. Buzas E.I., Hollo K., Rubliczky L., Garzo M., Nyirkos P., Glant T.T. Effect of pregnancy on proteoglycan-induced progressive polyarthritis in BALB/c mice: remission of disease activity. Clin Exp Immunol 1993, 94:252-260.
17. Cortes M., Canellada A., Miranda S., Dokmetjian J., Gentile T. Placental secreted factors: their role in the regulation of anti-CII antibodies and amelioration of collagen induced arthritis in rats. Immunol Lett 2008, 119:42-48.
18. Tzou S.C., Lupi I., Landek M., Gutenberg A., Tzou Y.M., Kimura H., et al. Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model. Endocrinology 2008, 149:3461-3469.
19. Tzou S.C., Landek-Salgado M.A., Kimura H., Caturegli P. Preparation of mouse pituitary immunogen for the induction of experimental autoimmune hypopohysitis. J Vis Exp 2010, 46. http://www.jove.com/details.stp%3Fid%3D2181, 10.3791/2181.
20. Kimura H., Kimura M., Tzou S.C., Chen Y.C., Suzuki K., Rose N.R., et al. Expression of class II major histocompatibility complex molecules on thyrocytes does not cause spontaneous thyroiditis but mildly increases its severity after immunization. Endocrinology 2005, 146:1154-1162.
21. Landek-Salgado M.A., Tzou S.C., Kimura H., Caturegli P. Induction of experimental autoimmune hypophysitis in SJL mice. J Vis Exp 2010, 46. https://www.jove.com/details.stp?id=2182, 10.3791/2182.
22. Jouvin-Marche E., Morgado M.G., Leguern C., Voegtle D., Bonhomme F., Cazenave P.A. The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes. Immunogenetics 1989, 29:92-97.
23. Flynn J.C., Conaway D.H., Cobbold S., Waldmann H., Kong Y.C. Depletion of L3T4+ and Lyt-2+ cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditis. Cell Immunol 1989, 122:377-390.
24. Healy J.I., Dolmetsch R.E., Timmerman L.A., Cyster J.G., Thomas M.L., Crabtree G.R., et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 1997, 6:419-428.
25. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385:729-733.
26. Reddy P., Slack J.L., Davis R., Cerretti D.P., Kozlosky C.J., Blanton R.A., et al. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 2000, 275:14608-14614.
27. Van Zee K.J., Kohno T., Fischer E., Rock C.S., Moldawer L.L., Lowry S.F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A 1992, 89:4845-4849.
28. Bradley J.R. TNF-mediated inflammatory disease. J Pathol 2008, 214:149-160.
29. Arntzen K.J., Liabakk N.B., Jacobsen G., Espevik T., Austgulen R. Soluble tumor necrosis factor receptor in serum and urine throughout normal pregnancy and at delivery. Am J Reprod Immunol 1995, 34:163-169.
30. Thevenon A.D., Zhou J.A., Megnekou R., Ako S., Leke R.G., Taylor D.W. Elevated levels of soluble TNF receptors 1 and 2 correlate with Plasmodium falciparum parasitemia in pregnant women: potential markers for malaria-associated inflammation. J Immunol 2010, 185:7115-7122.
31. Jash A., Kwon H.K., Sahoo A., Lee C.G., So J.S., Kim J., et al. Topical application of porcine placenta extract inhibits the progression of experimental contact hypersensitivity. J Ethnopharmacol 2011, 133:654-662.
32. Marini M., Bamias G., Rivera-Nieves J., Moskaluk C.A., Hoang S.B., Ross W.G., et al. TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc Natl Acad Sci U S A 2003, 100:8366-8371.
33. Furst D.E., Breedveld F.C., Kalden J.R., Smolen J.S., Burmester G.R., Bijlsma J.W., et al. Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. Ann Rheum Dis 2005, 64(Suppl. 4):iv2-14.
34. Garrison L., McDonnell N.D. Etanercept: therapeutic use in patients with rheumatoid arthritis. Ann Rheum Dis 1999, 58(Suppl. 1):I65-I69.
35. Targan S.R., Hanauer S.B., van Deventer S.J., Mayer L., Present D.H., Braakman T., et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997, 337:1029-1035.
36. Reich K., Nestle F.O., Papp K., Ortonne J.P., Evans R., Guzzo C., et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 2005, 366:1367-1374.
37. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999, 53:457-465. The Lenercept Multiple Sclerosis Study Group, The University of British Columbia MS/MRI Analysis GroupThe University of British Columbia MS/MRI Analysis Group.
38. van Oosten B.W., Barkhof F., Truyen L., Boringa J.B., Bertelsmann F.W., von Blomberg B.M., et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996, 47:1531-1534.
39. Gomez-Gallego M., Meca-Lallana J., Fernandez-Barreiro A. Multiple sclerosis onset during etanercept treatment. Eur Neurol 2008, 59:91-93.
40. Pfueller C.F., Seipelt E., Zipp F., Paul F. Multiple sclerosis following etanercept treatment for ankylosing spondylitis. Scand J Rheumatol 2008, 37:397-399.
41. Caturegli P., Newschaffer C., Olivi A., Pomper M.G., Burger P.C., Rose N.R. Autoimmune hypophysitis. Endocr Rev 2005, 26:599-614.
42. Tubridy N., Saunders D., Thom M., Asa S.L., Powell M., Plant G.T., et al. Infundibulohypophysitis in a man presenting with diabetes insipidus and cavernous sinus involvement. J Neurol Neurosurg Psychiatry 2001, 71:798-801.
43. Lecube A., Francisco G., Rodriguez D., Ortega A., Codina A., Hernandez C., et al. Lymphocytic hypophysitis successfully treated with azathioprine: first case report. J Neurol Neurosurg Psychiatry 2003, 74:1581-1583.
44. Hehlgans T., Mannel D.N. The TNF-TNF receptor system. Biol Chem 2002, 383:1581-1585.
45. De Togni P., Goellner J., Ruddle N.H., Streeter P.R., Fick A., Mariathasan S., et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994, 264:703-707.
46. Chiang E.Y., Kolumam G.A., Yu X., Francesco M., Ivelja S., Peng I., et al. Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease. Nat Med 2009, 15:766-773.
47. Sean Riminton D., Korner H., Strickland D.H., Lemckert F.A., Pollard J.D., Sedgwick J.D. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J Exp Med 1998, 187:1517-1528.
48. Van Rood J.J., Eernisse J.G., Van Leeuwen A. Leucocyte antibodies in sera from pregnant women. Nature 1958, 181:1735-1736.
49. Zuccotti G., Pogliani L., Pariani E., Amendola A., Zanetti A. Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine. Jama 2010, 304:2360-2361.
50. Erlebacher A. Immune surveillance of the maternal/fetal interface: controversies and implications. Trends Endocrinol Metab 2010, 21:428-434.